News of the index components OMX Copenhagen 20

Index

OMXC20

DK0016268840

Real-time Nasdaq Copenhagen 15:34:03 17/05/2024 BST			5-day change	1st Jan Change
2,725 ^PTS	-0.99%		-0.00%	+19.37%

05-15	Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders	DJ
05-14	Nordic Shares Closed Up Tuesday; Volvo Car Series B Led Increases	DJ

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novo Nordisk Plans First Bond Sale in Two Years NOVO B	05-14	MT
NOVO NORDISK : Stifel raises its target price NOVO B	05-14	CF
Transcript : Ambu A/S, Q2 2024 Earnings Call, May 14, 2024 AMBU B	05-14
Wegovy weight loss sustained for four years in trial, Novo Nordisk says NOVO B	05-14	RE
Notice of early redemption DANSKE	05-14	AQ
Danske Bank A/S : Impartial investigation of Danske Bank A/S’ debt collection - Report no. 5 DANSKE	05-14	PU
Coloplast expands its Luja™ portfolio with next generation catheter for women COLO B	05-14	GL
Novo Nordisk Taps Banks for Potential Bond Issue NOVO B	05-14	MT
Danske Bank A/S : Insider transaction disclosure no. 50 DANSKE	05-14	PU
Danske Bank A/S : Insider transaction disclosure no 50 DANSKE	05-14	PU
Danske Bank A/S, transactions by persons discharging managerial responsibilities DANSKE	05-14	GL
Ambu A/S : INTERIM REPORT FOR Q2 2023/24 AND THE HALF-YEAR AMBU B	05-14	PU
Novo Nordisk Reports Positive Results from Trial of Mim8 for Hemophilia A Treatment NOVO B	05-14	MT
Ambu A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 AMBU B	05-14	CI
Wegovy weight loss sustained for four years in trial, Novo Nordisk says NOVO B	05-14	RE
Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US NOVO B	05-13	MT
Novo Nordisk Shares Rise as it Says Antibody Found to Benefit Patients With Blood Condition NOVO B	05-13	MT
Novo Nordisk: positive trial in hemophilia care NOVO B	05-13	CF
Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial NOVO B	05-13	GL
Novo Nordisk Taps Banks for Potential Bond Issue NOVO B	05-13	MT
Denmark faces Wegovy shortage due to rising demand, medicines agency says NOVO B	05-13	RE
Transactions in Connection with Share Buy-back Program GMAB	05-13	GL
Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US NOVO B	05-13	MT
Novo Nordisk Plans First Bond Sale in 2 Years NOVO B	05-13	MT
Novo Nordisk Plans First Bond Sale in More Than 2 years, Bloomberg Says NOVO B	05-13	MT
Transcript : Royal Unibrew A/S - Analyst/Investor Day RBREW	05-13
Tampere University : Novo Nordisk Foundation grants 670 000 EUR to develop organ transplant assessment and drug discovery tool for epilepsy NOVO B	05-13	AQ
Danske Bank share buy-back programme: Transactions in week 19 DANSKE	05-13	GL
Launch of Long-Term Incentive Plan for executive management and key employees RBREW	05-13	GL
Transactions in connection with share buyback programme ISS	05-13	GL
Carlsberg A/S share buy-back programme CARL B	05-13	AQ
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows NOVO B	05-10	RE
NOVONESIS : Key segments outperform in average Q1 24 showing NSIS B	05-10
Novo Nordisk Partners With Metaphore Biotechnologies on New Obesity Drugs NOVO B	05-09	DJ
Novo Nordisk May Pay Up to $600 Million in R&D Deal With Metaphore Biotechnologies, Flagship Pioneering NOVO B	05-09	MT
Novo Nordisk Enters Research Partnership for New Weight Loss Drugs NOVO B	05-09	MT
Novo Nordisk May Pay Up to $600 Million in New Obesity R&D Deal NOVO B	05-09	MT
Novo Nordisk May Pay Up to $600 Million in New R&D Deal NOVO B	05-09	MT
Novo Nordisk Enters Research Partnership for New Weight Loss Drugs NOVO B	05-09	MT
Novo Nordisk ties up with Metaphore to develop new obesity drugs NOVO B	05-09	RE